Commentary: Mitigating Antibiotic Resistance Emissions in the Pharmaceutical Industry: Global Governance and Available Techniques

We highlight the paramount importance of pretreatment processes preceding the biological treatment of antibiotic manufacturing wastewater as a strategy to curb the escalation of antibiotic resistance. In an effort to curtail the advancement of antimicrobial resistance (AMR) in antibiotic production in China, a comprehensive array of technical and regulatory initiatives have been implemented. These measures offer valuable insights that could inform and enhance global AMR containment strategies. Looking ahead, there is a pressing need to form an interdisciplinary team tasked with refining antibiotic emission standards and tailoring environmental engineering practices for the pharmaceutical sector.

Clean Environment   Back